Skip to main content
Top
Published in: European Journal of Medical Research 1/2024

Open Access 01-12-2024 | Systemic Lupus Erythematosus | Research

Inhibition of STAT3 alleviates LPS-induced apoptosis and inflammation in renal tubular epithelial cells by transcriptionally down-regulating TASL

Authors: Jin-Wen Xu, Ming-Yan Wang, Yan Mao, Zheng-Yun Hu, Xiao-Lin Miao, Feng Jiang, Guo-Ping Zhou

Published in: European Journal of Medical Research | Issue 1/2024

Login to get access

Abstract

Background

Systemic lupus erythematosus (SLE) is a common autoimmune disease that impacts various organs. Lupus nephritis (LN) significantly contributes to death in children with SLE. Toll-like receptor (TLR) adaptor interacting with SLC15A4 on the lysosome (TASL) acts as an innate immune adaptor for TLR and is implicated in the pathogenesis of SLE. A transcription factor known as signal transducer and activator of transcription 3 (STAT3), which is known to be linked to autoimmune diseases, is also involved in the development of SLE.

Methods

Bioinformatics and real-time quantitative PCR (qRT-PCR) was used to detect the expression of STAT3 and TASL in peripheral blood of SLE patients and their correlation. Bioinformatics analysis, qRT-PCR, luciferase assay and chromatin immunoprecipitation (ChIP) were used to verify the regulation of transcription factor STAT3 on TASL. The expression levels of STAT3, TASL and apoptosis-related genes in LPS-induced HK2 cells were detected by qRT-PCR and Western blot. TUNEL staining were used to detect the apoptosis of HK2 cells after LPS stimulation. ELISA and qRT-PCR were used to detect the levels of inflammatory cytokines in the cell culture supernatant. TASL knockdown in HK2 cells was used to detect the changes in apoptosis-related genes and inflammatory factors. The expression level of TASL in LPS-stimulated HK2 cells and its effect on cell apoptosis and inflammatory factors were observed by knocking down and overexpressing STAT3, respectively. It was also verified in a rescue experiment.

Results

The expressions of STAT3 and TASL were higher in SLE than in healthy children, and the expression of STAT3 was positively correlated with TASL. Transcription factor STAT3 can directly and positively regulate the expression of TASL through the promoter region binding site. The expression of STAT3, TASL and inflammatory cytokines was elevated, and the change of apoptosis was up-regulated in LPS-stimulated HK2 cells. Inhibition of STAT3 alleviates LPS-stimulated apoptosis and inflammatory response in HK2 cells through transcriptional regulation of TASL.

Conclusions

These findings provide new insights into the transcriptional regulation of TASL and provide new evidence of a direct regulatory relationship between signaling nodes in the lupus signaling network.

Graphical Abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023;74:339–52.CrossRefPubMed Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med. 2023;74:339–52.CrossRefPubMed
2.
3.
go back to reference Yu C, Li P, Dang X, et al. Lupus nephritis: new progress in diagnosis and treatment. J Autoimmun. 2022;132: 102871.CrossRefPubMed Yu C, Li P, Dang X, et al. Lupus nephritis: new progress in diagnosis and treatment. J Autoimmun. 2022;132: 102871.CrossRefPubMed
5.
go back to reference Chen XC, Wu D, Wu HL, et al. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway. Lupus Sci Med. 2022;9(1): e000611.CrossRefPubMedPubMedCentral Chen XC, Wu D, Wu HL, et al. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway. Lupus Sci Med. 2022;9(1): e000611.CrossRefPubMedPubMedCentral
6.
go back to reference Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–35.CrossRefPubMed Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–35.CrossRefPubMed
7.
go back to reference Hanly JG, O’Keeffe AG, Su L, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology. 2016;55(2):252–62.CrossRefPubMed Hanly JG, O’Keeffe AG, Su L, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology. 2016;55(2):252–62.CrossRefPubMed
8.
go back to reference Pesce F, Stea ED, Rossini M, et al. Glomerulonephritis in AKI: from pathogenesis to therapeutic intervention. Front Med. 2020;7: 582272.CrossRef Pesce F, Stea ED, Rossini M, et al. Glomerulonephritis in AKI: from pathogenesis to therapeutic intervention. Front Med. 2020;7: 582272.CrossRef
10.
go back to reference Psarras A, Alase A, Antanaviciute A, et al. Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nat Commun. 2020;11(1):6149.CrossRefPubMedPubMedCentral Psarras A, Alase A, Antanaviciute A, et al. Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nat Commun. 2020;11(1):6149.CrossRefPubMedPubMedCentral
12.
go back to reference Niewold TB, Hua J, Lehman TJ, et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8(6):492–502.CrossRefPubMedPubMedCentral Niewold TB, Hua J, Lehman TJ, et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8(6):492–502.CrossRefPubMedPubMedCentral
13.
go back to reference Sengupta S, Bhattacharya G, Mohanty S, et al. IL-21, inflammatory cytokines and hyperpolarized CD8(+) T cells are central players in lupus immune pathology. Antioxidants. 2023;12(1):181.CrossRefPubMedPubMedCentral Sengupta S, Bhattacharya G, Mohanty S, et al. IL-21, inflammatory cytokines and hyperpolarized CD8(+) T cells are central players in lupus immune pathology. Antioxidants. 2023;12(1):181.CrossRefPubMedPubMedCentral
14.
go back to reference Teruel M, Alarcon-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun. 2016;74:161–75.CrossRefPubMed Teruel M, Alarcon-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun. 2016;74:161–75.CrossRefPubMed
16.
go back to reference Schwickert TA, Tagoh H, Schindler K, et al. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells. Nat Immunol. 2019;20(11):1517–29.CrossRefPubMedPubMedCentral Schwickert TA, Tagoh H, Schindler K, et al. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells. Nat Immunol. 2019;20(11):1517–29.CrossRefPubMedPubMedCentral
17.
go back to reference Couronne L, Scourzic L, Pilati C, et al. STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. Haematologica. 2013;98(11):1748–52.CrossRefPubMedPubMedCentral Couronne L, Scourzic L, Pilati C, et al. STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. Haematologica. 2013;98(11):1748–52.CrossRefPubMedPubMedCentral
18.
go back to reference De Groof A, Ducreux J, Aleva F, et al. STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE. Rheumatology. 2020;59(3):668–77.PubMed De Groof A, Ducreux J, Aleva F, et al. STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE. Rheumatology. 2020;59(3):668–77.PubMed
19.
go back to reference Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264(5155):95–8.CrossRefPubMed Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994;264(5155):95–8.CrossRefPubMed
21.
go back to reference Edwards LJ, Mizui M, Kyttaris V. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice. Clin Immunol. 2015;158(2):221–30.CrossRefPubMedPubMedCentral Edwards LJ, Mizui M, Kyttaris V. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice. Clin Immunol. 2015;158(2):221–30.CrossRefPubMedPubMedCentral
23.
go back to reference Xu ZQ, Ding Y, Huang XY, et al. CircELK4 contributes to lupus nephritis by acting as a miR-27b-3p sponge to regulate STING/IRF3/IFN-I signaling. Inflammation. 2021;44(5):2106–19.CrossRefPubMed Xu ZQ, Ding Y, Huang XY, et al. CircELK4 contributes to lupus nephritis by acting as a miR-27b-3p sponge to regulate STING/IRF3/IFN-I signaling. Inflammation. 2021;44(5):2106–19.CrossRefPubMed
24.
25.
go back to reference Cortini A, Ellinghaus U, Malik TH, et al. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis. Ann Rheum Dis. 2017;76(12):2095–103.CrossRefPubMed Cortini A, Ellinghaus U, Malik TH, et al. B cell OX40L supports T follicular helper cell development and contributes to SLE pathogenesis. Ann Rheum Dis. 2017;76(12):2095–103.CrossRefPubMed
26.
go back to reference Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93(3):568–79.CrossRefPubMed Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93(3):568–79.CrossRefPubMed
27.
go back to reference Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947–56.CrossRefPubMed Azzouz D, Omarbekova A, Heguy A, et al. Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Ann Rheum Dis. 2019;78(7):947–56.CrossRefPubMed
28.
go back to reference Gomez Mendez LM, Cascino MD, Garg J, et al. Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis. Clin J Am Soc Nephrol. 2018;13(10):1502–9.CrossRefPubMedPubMedCentral Gomez Mendez LM, Cascino MD, Garg J, et al. Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis. Clin J Am Soc Nephrol. 2018;13(10):1502–9.CrossRefPubMedPubMedCentral
29.
go back to reference Yung S, Chan TM. Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review. Clin Rev Allergy Immunol. 2017;52(2):149–63.CrossRefPubMed Yung S, Chan TM. Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review. Clin Rev Allergy Immunol. 2017;52(2):149–63.CrossRefPubMed
30.
go back to reference Westerterp M, Gautier EL, Ganda A, et al. Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity. Cell Metab. 2017;25(6):1294–304.CrossRefPubMedPubMedCentral Westerterp M, Gautier EL, Ganda A, et al. Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity. Cell Metab. 2017;25(6):1294–304.CrossRefPubMedPubMedCentral
31.
go back to reference Kahlenberg JM, Carmona-Rivera C, Smith CK, et al. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol. 2013;190(3):1217–26.CrossRefPubMed Kahlenberg JM, Carmona-Rivera C, Smith CK, et al. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol. 2013;190(3):1217–26.CrossRefPubMed
32.
go back to reference Brightbill HD, Suto E, Blaquiere N, et al. NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus. Nat Commun. 2018;9(1):179.CrossRefPubMedPubMedCentral Brightbill HD, Suto E, Blaquiere N, et al. NF-kappaB inducing kinase is a therapeutic target for systemic lupus erythematosus. Nat Commun. 2018;9(1):179.CrossRefPubMedPubMedCentral
33.
go back to reference Adamichou C, Georgakis S, Bertsias G. Cytokine targets in lupus nephritis: current and future prospects. Clin Immunol. 2019;206:42–52.CrossRefPubMed Adamichou C, Georgakis S, Bertsias G. Cytokine targets in lupus nephritis: current and future prospects. Clin Immunol. 2019;206:42–52.CrossRefPubMed
34.
go back to reference Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16(5):527–38.CrossRefPubMed Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol. 2020;16(5):527–38.CrossRefPubMed
35.
go back to reference Song F, Yi Y, Li C, et al. Regulation and biological role of the peptide/histidine transporter SLC15A3 in Toll-like receptor-mediated inflammatory responses in macrophage. Cell Death Dis. 2018;9(7):770.CrossRefPubMedPubMedCentral Song F, Yi Y, Li C, et al. Regulation and biological role of the peptide/histidine transporter SLC15A3 in Toll-like receptor-mediated inflammatory responses in macrophage. Cell Death Dis. 2018;9(7):770.CrossRefPubMedPubMedCentral
36.
go back to reference Harris VM, Harley ITW, Kurien BT, et al. Lysosomal pH is regulated in a sex dependent manner in immune cells expressing CXorf21. Front Immunol. 2019;10:578.CrossRefPubMedPubMedCentral Harris VM, Harley ITW, Kurien BT, et al. Lysosomal pH is regulated in a sex dependent manner in immune cells expressing CXorf21. Front Immunol. 2019;10:578.CrossRefPubMedPubMedCentral
38.
go back to reference Lambers WM, Westra J, Bootsma H, et al. Hydroxychloroquine suppresses interferon-inducible genes and B cell activating factor in patients with incomplete and new-onset systemic lupus erythematosus. J Rheumatol. 2021;48(6):847–51.CrossRefPubMed Lambers WM, Westra J, Bootsma H, et al. Hydroxychloroquine suppresses interferon-inducible genes and B cell activating factor in patients with incomplete and new-onset systemic lupus erythematosus. J Rheumatol. 2021;48(6):847–51.CrossRefPubMed
Metadata
Title
Inhibition of STAT3 alleviates LPS-induced apoptosis and inflammation in renal tubular epithelial cells by transcriptionally down-regulating TASL
Authors
Jin-Wen Xu
Ming-Yan Wang
Yan Mao
Zheng-Yun Hu
Xiao-Lin Miao
Feng Jiang
Guo-Ping Zhou
Publication date
01-12-2024
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2024
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01610-9

Other articles of this Issue 1/2024

European Journal of Medical Research 1/2024 Go to the issue